Exploring regulatory data sets of the Comirnaty vaccine - 14

We are still confused, but we are in good company.

We started the Comirnaty series just after Easter to explore what data regulators had in front of them when they decided to grant Comirnaty provisional registration in the middle of the Covid panic in December 2020.

Exploring regulatory data sets of the Comirnaty vaccine - 13

We have summarised our findings and reflections several times, going slow and adopting a neutral stance. Occasionally, our summaries were one post with summary slides, and sometimes, it took three posts to wrap the “sofar” up.

The latest summing up could be this:

Serious harms - depends on who you ask;

Transmission not tested; move along, please;

Carcinogenicity and genotoxicity not tested; keep moving, please;

Pregnant and lactating women were excluded from the registration trial;

Effects in pregnancy and lactation later tested but not published; 

Pharmacokinetics—let's not go there, as regulators are not interested in what the mmRNA does or goes once inside you;

As for the m in mmMRA, it stands for modified; 

As for ‘is Cominarty a drug or a vaccine’, please don’t pose difficult…